Paramount Wants a November Trial; States Want April. That 7-Month Gap Just Got More Expensive.

The trial-date fight is really a fight over time, money, and leverage

This is less about courtroom scheduling than about who can withstand delay. Paramount wants a Nov. 4 trial. The 12 state attorneys general and the WGA want an April 5, 2027 trial. The seven-month gap matters because every extra month raises the odds that momentum shifts, costs mount, and the parties face more pressure to renegotiate terms.

Why the calendar matters

Paramount wants speed because time now hits the deal economics directly. If the merger has not closed by September 30, Paramount must pay a ticking fee of about $7 million per day. That makes a later trial not just a legal delay but an expensive one.

Who benefits from delay

Delay is already costly. Paramount has agreed to push the merger into June 1, 2027 or five days after the judge rules, whichever comes first, even though a run-through to June could mean more than $1.9 billion in ticking fees, according to Forbes. For WBD holders, a later trial can mean extra compensation for waiting. For Paramount, it means more exposure to scrutiny, financing strain, and the possibility of tougher conditions if the deal eventually closes.

Why the plaintiffs want more time and why Paramount resists

The plaintiffs no longer have the benefit of an emergency block. What they do have is a request for an April 5, 2027 trial with 12 to 15 days of proceedings, paired with a closing deadline pushed to June 1, 2027. That suggests a strategy centered on extending the process rather than forcing an immediate injunction.

Discovery time becomes bargaining power

In an antitrust case, additional time means more discovery and a deeper record. The states have said they want to examine market definition, potential harm, competitive responses, and whether merger-specific efficiencies would offset that harm. From their perspective, more time can strengthen both their trial position and any later settlement leverage.

Paramount's response is simpler. It says a trial on the merits can happen sooner and that November would give both sides enough time to prepare. The two sides also trade sharper characterizations: Paramount calls the spring date a stonewalling tactic, while the states argue a shorter schedule would be artificially compressed and unworkable.

Why the judge's choice matters now

The practical effect of the scheduling dispute is straightforward. A later trial increases the time the deal spends in limbo, which can affect financing, shareholder sentiment, and the terms under which the transaction might eventually close. That is why the calendar question matters as much as the legal argument.

The price floor still matters, but delay is now part of the economics

Investors are not watching this fight only for legal signals. Paramount is still backing its $30 per share all-cash offer, and it has also agreed to pay Warner investors at least $31 a share if the transaction survives the court process. That creates a price floor, but it does not remove the cost of delay.

The court schedule now sits directly between that floor and final closing. Paramount has agreed to close as late as June 1, 2027 or five days after a ruling, whichever comes first, while a daily ticking fee to Warner shareholders can keep adding up if the deal misses its original benchmark. In other words, the trial date is no longer just procedure. It is part of the investment case.